Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Your confirmation email is on its way. Please check your inbox for further instructions.

Vericel (VCEL) Stock Forecast & Price Target

Vericel logo
$52.74 -2.73 (-4.92%)
(As of 11/14/2024 ET)

Vericel - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
7

Based on 7 Wall Street analysts who have issued ratings for Vericel in the last 12 months, the stock has a consensus rating of "Buy." Out of the 7 analysts, 7 have given a buy rating for VCEL.

Consensus Price Target

$57.71
9.43% Upside
According to the 7 analysts' twelve-month price targets for Vericel, the average price target is $57.71. The highest price target for VCEL is $60.00, while the lowest price target for VCEL is $55.00. The average price target represents a forecasted upside of 9.43% from the current price of $52.74.

VCEL Analyst Ratings Over Time

TypeCurrent Forecast
11/16/23 to 11/15/24
1 Month Ago
10/17/23 to 10/16/24
3 Months Ago
8/18/23 to 8/17/24
1 Year Ago
11/16/22 to 11/16/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
9 Buy rating(s)
9 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$57.71$55.75$55.13$41.70
Forecasted Upside9.43% Upside35.09% Upside19.11% Upside17.20% Upside
Consensus Rating
Buy
Buy
Buy
Moderate Buy

VCEL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VCEL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Vericel Stock vs. The Competition

TypeVericelMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside9.43% Upside27,207.90% Upside8.87% Upside
News Sentiment Rating
Positive News

See Recent VCEL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024HC Wainwright
2 of 5 stars
 Reiterated RatingBuy ➝ Buy$60.00 ➝ $60.00+19.93%
8/27/2024TD Cowen
4 of 5 stars
J. Jennings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$55.00 ➝ $60.00+14.55%
8/9/2024Canaccord Genuity Group
1 of 5 stars
 Initiated CoverageBuy$57.00+23.24%
8/2/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$56.00 ➝ $58.00+23.93%
7/16/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$56.00 ➝ $57.00+10.85%
7/15/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$56.00 ➝ $55.00+11.65%
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

10/16/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kratky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
10/16/2023Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$42.00+28.01%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:45 AM ET.


VCEL Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Vericel is $57.71, with a high forecast of $60.00 and a low forecast of $55.00.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vericel in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" VCEL shares.

According to analysts, Vericel's stock has a predicted upside of 9.43% based on their 12-month stock forecasts.

Vericel has been rated by research analysts at HC Wainwright, and TD Cowen in the past 90 days.

Analysts like Vericel more than other "medical" companies. The consensus rating for Vericel is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how VCEL compares to other companies.


This page (NASDAQ:VCEL) was last updated on 11/15/2024 by MarketBeat.com Staff
From Our Partners